Harrow Health, Inc. 8.625% Senior Notes due 2026 (NASDAQ:HROWL) Short Interest Update

Harrow Health, Inc. 8.625% Senior Notes due 2026 (NASDAQ:HROWL) saw a significant decline in short interest in the month of October. As of October 31st, there was short interest totalling 700 shares, a decline of 22.2% from the October 15th total of 900 shares. Based on an average daily volume of 4,000 shares, the short-interest ratio is presently 0.2 days.

Harrow Health, Inc. 8.625% Senior Notes due 2026 Stock Performance

HROWL stock traded down $0.08 during trading on Friday, hitting $25.30. The company had a trading volume of 4,627 shares, compared to its average volume of 5,571. Harrow Health, Inc. 8.625% Senior Notes due 2026 has a one year low of $22.70 and a one year high of $25.73. The business has a 50-day moving average of $25.43 and a 200-day moving average of $25.25.

Harrow Health, Inc. 8.625% Senior Notes due 2026 Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Thursday, October 31st. Shareholders of record on Tuesday, October 15th were issued a $0.5391 dividend. This represents a $2.16 dividend on an annualized basis and a yield of 8.52%. The ex-dividend date of this dividend was Tuesday, October 15th.

About Harrow Health, Inc. 8.625% Senior Notes due 2026

harrow health, inc., together with its subsidiaries, develops, produces, and sells medications for unmet needs primarily in the united states. the company primarily provides ophthalmology based formulations to physicians and patients; and sterile and non-sterile compounded medications. it also develops and commercializes therapeutics for treating ocular surface diseases; and non-intravenous sedation and anesthesia therapeutics for human medical procedures in hospital, outpatient, and in-office settings.